News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CEL-SCI (CVM) Receives Approval For Listing And Trading Of Warrants From The NYSE MKT Under The Ticker Symbol "CVM WS"


2/5/2014 5:17:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announced today that the warrants issued in connection with the public offerings in October and December 2013 are approved for trading on the NYSE MKT and will begin trading on February 7, 2014 under the ticker symbol “CVM WS”. CEL-SCI issued 25,713,095 warrants to over 250 investors who participated in the public offerings. The warrants are exercisable at $1.25 and expire on October 11, 2018. These warrants were previously approved for trading on the OTC Bulletin Board under the ticker symbol “CSCIW”. CEL-SCI also received approval for electronic delivery of the warrants from the Depository Trust Company. Investors who participated in the public offering were sent information by mail from Computershare Trust Company (“the Warrant Agent”) with instructions on how to trade in the “old” warrants for “new” warrants certificates that can be deposited with a broker electronically.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES